Organization
Hoffmann-La Roche
Swiss drug company; maker of Accutane.
- Also known as
- Roche
- Wikidata
- Q212646
Connections 7
launched
- Accutane (isotretinoin) 1982 Primary record 1
involved in
- Accutane lawsuits in New Jersey defendant; says there is no reliable scientific evidence that Accutane causes inflammatory bowel disease According to Hoffmann-La Roche Scholarship & press 2
- Accutane lawsuits in New Jersey first verdict, 2007 (failure to warn; no consumer fraud), vacated on appeal for erroneous evidentiary rulings Scholarship & press 3
- Accutane lawsuits in New Jersey retrial verdict, 2010, reversed by the Appellate Division as time-barred Scholarship & press 3
- Accutane lawsuits in New Jersey the New Jersey Supreme Court reinstated the $25 million verdict in January 2017 Scholarship & press 4
- Accutane lawsuits in New Jersey the Appellate Division vacated the verdict again on 2 May 2017, apparently heading for a third trial, a law-firm blog says; we did not find what followed Scholarship & press 3
- Accutane lawsuits in New Jersey 532 claims were before the New Jersey Supreme Court in 2018 Scholarship & press 5
Timeline 1 date
- 1982 Hoffmann-La Roche launched Accutane (isotretinoin)
Proof 5 sources
-
Determination That ACCUTANE (Isotretinoin) Capsules, 10 Milligrams, 20 Milligrams, and 40 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness (Federal Register), U.S. Food and Drug Administration, 7 Jul 2010.
Primary record
ACCUTANE (isotretinoin) Capsules, 10 mg, 20 mg, and 40 mg, are the subject of NDA 18-662, held by Hoffman-La Roche, Inc. (Roche), and initially approved on May 7, 1982.
-
Roche to appeal $2.62 million judgment in Accutane case, Dermatology Times, 1 Jul 2007.
Scholarship & press
Notwithstanding the verdict, the cause of inflammatory bowel disease remains unknown, and there is no reliable scientific evidence that Accutane causes inflammatory bowel disease.
-
Another Accutane Verdict Vacated in New Jersey, Drug and Device Law (law-firm blog).
Scholarship & press
The case was first tried to a jury in 2007, resulting in a verdict for the plaintiff. But the Appellate Division vacated that award and remanded for a new trial because of erroneous evidentiary rulings.
The parties therefore tried the case again in 2010, which resulted in a larger verdict for the plaintiff. On appeal from the second verdict, the Appellate Division reversed again and held that the claims were time barred.
The latest shoe dropped last week when the New Jersey Appellate Division vacated (again) a jury verdict in favor of an Accutane plaintiff.
-
Court gives man $25M award in acne drug case (AP, via NJ 101.5), The Associated Press, via NJ 101.5.
Scholarship & press
New Jersey's top court has reinstated a $25 million jury award for an Alabama man who became seriously ill after taking an acne drug.
-
In re Accutane Litigation: opinion summary (Justia, New Jersey Supreme Court opinion summaries), Justia.
Scholarship & press
This appeal arose from 532 product-liability claims filed against Hoffmann-La Roche Inc. and Roche Laboratories Inc.
Page history 1 change
- Add 55 stories, each checked against its sources96e92fe6
Something wrong or missing? Tell us, with a source, or edit this page.